Caxton Associates (New York)’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | $720K | Sell |
33,619
-2,661
| -7% | -$57K | 0.02% | 269 |
|
2024
Q3 | $1.13M | Buy |
+36,280
| New | +$1.13M | 0.04% | 218 |
|
2024
Q2 | – | Sell |
-96,308
| Closed | -$1.02M | – | 486 |
|
2024
Q1 | $1.02M | Buy |
96,308
+47,469
| +97% | +$503K | 0.06% | 212 |
|
2023
Q4 | $586K | Hold |
48,839
| – | – | 0.03% | 299 |
|
2023
Q3 | $342K | Buy |
48,839
+21,105
| +76% | +$148K | 0.05% | 289 |
|
2023
Q2 | $236K | Buy |
+27,734
| New | +$236K | 0.03% | 388 |
|
2020
Q3 | – | Sell |
-8,948
| Closed | -$317K | – | 325 |
|
2020
Q2 | $317K | Buy |
+8,948
| New | +$317K | 0.03% | 225 |
|
2018
Q4 | – | Sell |
-6,965
| Closed | -$201K | – | 291 |
|
2018
Q3 | $201K | Buy |
+6,965
| New | +$201K | 0.01% | 332 |
|